Division of Cardiovascular Medicine, Mayo Clinic and Mayo Foundation, Rochester, MN (M.A.A.-H., R.G., A.E.S., J.Y.P., A.K., A.B., A.L., D.R.H., M.B., M.S.).
Division of Biomedical Statistics and Informatics, Mayo Clinic and Mayo Foundation, Rochester, MN(R.J.L., D.C.).
Circ Cardiovasc Interv. 2019 Jul;12(7):e007791. doi: 10.1161/CIRCINTERVENTIONS.119.007791. Epub 2019 Jul 9.
We aim to study the incidence of major complications related to procedure defined as in-hospital death, myocardial infarction, stroke, pericardial effusion or tamponade, percutaneous coronary intervention due to iatrogenic coronary dissection, or unplanned bypass surgery within 72 hours after diagnostic left heart catheterization (LHC; primary end point). Furthermore, all causes of in-hospital death after LHC were adjudicated and reported (secondary end point).
Diagnostic LHC procedures (aortic angiography; coronary, including graft, angiography; and left ventricular angiography) from January 1, 2002, through December 31, 2013, were identified using the clinical scheduling system at Mayo Clinic, Rochester, and complications were identified through electronic records. International Classification of Diseases, Ninth Revision billing codes were used. Registration was queried to identify all-cause mortality. All events were reviewed and adjudicated. There were 43 786 diagnostic LHC procedures; 97.3% were coronary angiograms. The mean age of patients was 64.5 years (13.6), and the majority were male (61.5%). Primary end point was seen in 36 (0.082%) procedures or 8.2 of 10 000 LHCs. Combined right sided procedures with LHC did not increase the risk of major complications. Cardiogenic and septic shock, cardiac arrhythmia, and postsurgical complication were the most common causes of in-hospital death after LHC.
The overall rates of major complications related to diagnostic cardiac catheterization procedures are extremely rare. The majority of the deaths occurring post-diagnostic LHC procedures were secondary to acute illness rather than directly related to diagnostic procedure.
我们旨在研究与院内死亡、心肌梗死、中风、心包积液或填塞、医源性冠状动脉夹层引起的经皮冠状动脉介入治疗或计划外旁路手术后 72 小时内的主要并发症相关的发生率,定义为程序(主要终点)。此外,还对 LHC 后所有院内死亡原因进行了裁决和报告(次要终点)。
使用罗切斯特梅奥诊所的临床排班系统,从 2002 年 1 月 1 日至 2013 年 12 月 31 日确定诊断性左心导管检查(LHC)程序(主动脉造影;冠状动脉,包括移植血管,造影;和左心室造影),并通过电子记录确定并发症。使用国际疾病分类,第九版计费代码。注册查询识别全因死亡率。所有事件均进行审查和裁决。共进行了 43786 例诊断性 LHC 检查;97.3%为冠状动脉造影。患者的平均年龄为 64.5 岁(13.6),大多数为男性(61.5%)。主要终点为 36 例(0.082%)或 10000 例 LHC 中的 8.2 例。与 LHC 联合进行右侧程序并不会增加主要并发症的风险。心源性和感染性休克、心律失常和手术后并发症是 LHC 后院内死亡的最常见原因。
与诊断性心脏导管检查程序相关的主要并发症的总体发生率极低。LHC 后发生的大多数死亡是继发于急性疾病,而不是直接与诊断程序相关。